Substituted 1H-imidazo[4,5-b]pyridin-2(3H)-ones and their use as GLUN2B receptor modulators

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 11759455
APP PUB NO 20230000833A1
SERIAL NO

17474631

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

Substituted 1H-imidazo[4,5-b]pyridin-2(3H)-ones as NR2B receptor ligands. Such compounds may be used in NR2B receptor modulation and in pharmaceutical compositions and methods for the treatment of disease states, disorders, and conditions mediated by NR2B receptor activity.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

  • JANSSEN PHARMACEUTICA NV

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Chrovian, Christa C La Jolla, US 23 187
Letavic, Michael A San Diego, US 80 669
Rech, Jason C Ann Arbor, US 20 170
Rudolph, Dale A San Diego, US 46 254
Soyode-Johnson, Akinola San Diego, US 23 212
Stenne, Brice M La Jolla, US 17 136
Wall, Jessica L San Diego, US 12 124

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
3.5 Year Payment $1600.00 $800.00 $400.00 Mar 19, 2027
7.5 Year Payment $3600.00 $1800.00 $900.00 Mar 19, 2031
11.5 Year Payment $7400.00 $3700.00 $1850.00 Mar 19, 2035
Fee Large entity fee small entity fee micro entity fee
Surcharge - 3.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 7.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00